Literature DB >> 34767243

MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.

Huier Sun1, Xuejun Chen2.   

Abstract

The objective of this study was to investigate modulatory mechanism of miR-106b-5p and tissue inhibitor of metalloproteinases 2 (TIMP2) on cervical squamous cell carcinoma cells. Differentially expressed genes in CSCC were analyzed via bioinformatics analysis. The targeting impact of miR-106b-5p on TIMP2 was validated through dual-luciferase assay and RNA immunoprecipitation assay. MiR-106b-5p level and TIMP2 mRNA level were assessed via qRT-PCR. TIMP2 protein level was measured via western blot. Malignant behaviors of CSCC cells were evaluated by functional experiments. The EMT and apoptosis-related proteins were determined via western blot. MiR-106b-5p was noticeably elevated in CSCC cells. Its downstream target was TIMP2. MiR-106b-5p and TIMP2 levels were inversely correlated. MiR-106b-5p overexpression fostered malignant phenotypes of CSCC cells, and vice versus. TIMP2 overexpression weakened the promotive impact of forced expression of miR-106b-5p on CSCC cell growth. EMT was facilitated by forced expression of miR-106b-5p. MiR-106b-5p regulates the progression of CSCC cells via targeting TIMP2, which may provide novel value for development of therapeutic targets for CSCC.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  Cervical squamous cell carcinoma; Invasion; MiR-106b-5p; Migration; Proliferation; TIMP2

Mesh:

Substances:

Year:  2021        PMID: 34767243     DOI: 10.1007/s43032-021-00788-9

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  40 in total

1.  MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.

Authors:  Mei Liu; Jusheng An; Manni Huang; Liming Wang; Binbin Tu; Yan Song; Kai Ma; Yu Wang; Shuren Wang; Hongxia Zhu; Ningzhi Xu; Lingying Wu
Journal:  Mol Carcinog       Date:  2017-08-28       Impact factor: 4.784

Review 2.  miR-146a-5p: Expression, regulation, and functions in cancer.

Authors:  Joseph R Iacona; Carol S Lutz
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-03-20       Impact factor: 9.957

3.  Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer.

Authors:  Juan Wang; Tao Wang; Yun-Yi Yang; Yan-Lan Chai; Fan Shi; Z I Liu
Journal:  Mol Clin Oncol       Date:  2014-11-24

4.  miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC.

Authors:  Jianxiang Zhang; Danjie Chen; Shuying Liang; Jun Wang; Can Liu; Caiping Nie; Zhengzheng Shan; Liuxing Wang; Qinxia Fan; Feng Wang
Journal:  Oncol Lett       Date:  2018-01-25       Impact factor: 2.967

5.  miRBase: tools for microRNA genomics.

Authors:  Sam Griffiths-Jones; Harpreet Kaur Saini; Stijn van Dongen; Anton J Enright
Journal:  Nucleic Acids Res       Date:  2007-11-08       Impact factor: 16.971

6.  Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma.

Authors:  Zemin Pan; Weinan Zheng; Jinli Zhang; Rui Gao; Dongmei Li; Xiaoqing Guo; Hu Han; Feng Li; Shen Qu; Renfu Shao
Journal:  BMC Cancer       Date:  2014-06-10       Impact factor: 4.430

Review 7.  Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.

Authors:  Maria M Caffarel; Nicholas Coleman
Journal:  J Pathol       Date:  2014-03       Impact factor: 7.996

8.  MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.

Authors:  Kang-Tai Lv; Zhu Liu; Jie Feng; Wei Zhao; Tao Hao; Wen-Yan Ding; Jing-Ping Chu; Ling-Juan Gao
Journal:  Int J Med Sci       Date:  2018-01-01       Impact factor: 3.738

Review 9.  Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer.

Authors:  Hongyu Liu; Cheng Lei; Qin He; Zou Pan; Desheng Xiao; Yongguang Tao
Journal:  Mol Cancer       Date:  2018-02-22       Impact factor: 27.401

10.  Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.

Authors:  Xinyan Wang; Jianwei Zhu
Journal:  Thorac Cancer       Date:  2018-04-26       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.